HTGM - VBIV and HTGM among premarket losers June, 17 2019 09:09 AM HTG Molecular Diagnostics Inc. VBI Vaccines (NASDAQ:VBIV) -54% on announcing top-line results from PROTECT, a Phase 3 Study of Sci-B-Vac.More news on: VBI Vaccines Inc., Outlook Therapeutics, Inc., HTG Molecular Diagnostics, Inc., Stocks on the move, Read more ...